Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Private placement grosses $10mm for D-Pharm

Executive Summary

Israeli biotech D-Pharm (lipid-mimicking medicines for neurological diseases and cancer) raised $10mm in a private financing. The round was led by Clal Biotechnology Industries, Israel Healthcare Ventures, and Pitango Venture Capital and included returning backers Care Capital, Gemini, and Polar Communications. Members from Israel Healthcare Ventures and Pitango Venture Capital will take seats on D-Pharm's board.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies